首页 | 本学科首页   官方微博 | 高级检索  
     

肝细胞癌TACE术后病灶存活或复发18F-FDGPET/CT和增强CT诊断价值Meta分析
引用本文:张穹,刘纯,陈明,彭珍珍. 肝细胞癌TACE术后病灶存活或复发18F-FDGPET/CT和增强CT诊断价值Meta分析[J]. 中华肿瘤防治杂志, 2021, 0(4): 302-309
作者姓名:张穹  刘纯  陈明  彭珍珍
作者单位:兰州大学第一医院核医学科
基金项目:甘肃省自然科学基金(18JR3RA355)。
摘    要:目的采用Meta分析方法评价18F-脱氧葡萄糖正电子发射计算机体层摄影(18F-FDG PET/CT)和增强CT(CECT)诊断经导管肝动脉化疗栓塞术(TACE)术后存活或复发病灶的临床价值。方法根据PRISMA报告规范开展Meta分析。检索PubMed、Embase、Cochrane Library、Web of Science、中国知网、万方和维普数据库中18F-FDG PET/CT和CECT诊断TACE术后存活或复发病灶的临床研究,时间至2019-04。由2位研究人员独立筛选文献、提取资料,根据诊断准确性研究质量评价工具-2(QUADAS-2)评价纳入研究的偏倚风险后,采用Stata 12.0软件进行Meta分析,计算其汇总敏感度(Sen)和特异度(Spe),绘制受试者工作特征曲线(SROC)并计算曲线下面积(AUC)。结果共纳入10篇18F-FDG PET/CT及13篇CECT诊断TACE术后存活或复发病灶的原始研究,分别包括322例患者的467个病灶和748例患者的943个病灶。Meta分析显示,18F-FDG PET/CT诊断TACE术后存活或复发病灶的Sen=0.92(95%CI为0.87~0.94)、Spe=0.95(95%CI为0.82~0.99)、AUC=0.97(95%CI为0.93~0.99);CECT诊断TACE术后存活或复发病灶的Sen=0.72(95%CI为0.66~0.78)、Spe=0.99(95%CI为0.93~1.00)、AUC=0.87(95%CI为0.83~0.89)。此外,CECT诊断TACE术后存活或复发Sen(Z=2.34,P=0.02)和AUC(Z=2.21,P=0.03)值低于18F-FDG PET/CT,差异有统计学意义。结论相比于CECT,18F-FDG PET/CT对TACE术后存活或复发病灶具有较高诊断效能,可视为TACE术后存活或复发病灶有效的影像学诊断方法。

关 键 词:18F-脱氧葡萄糖正电子发射计算机体层摄影  增强CT  经导管肝动脉化疗栓塞术  META分析

Value of 18F-FDG PET/CT and contrast enhnced CT in diagnosing residual or recurrent leision after TACE:A Meta-analysis
ZHANG Qiong,LIU Chun,CHEN Ming,PENG Zhen-zhen. Value of 18F-FDG PET/CT and contrast enhnced CT in diagnosing residual or recurrent leision after TACE:A Meta-analysis[J]. Chinese Journal of Cancer Prevention and Treatment, 2021, 0(4): 302-309
Authors:ZHANG Qiong  LIU Chun  CHEN Ming  PENG Zhen-zhen
Affiliation:(Department of Nuclear Medicine First Hospital of Lanzhou University.Lanzhou 730000,China)
Abstract:Objective To evaluate the clinical value of 18F-FDG PET/CT and contrast enhanced computed tomography(CECT)in diagnosing residual or recurrent leision after TACE.Methods This meta analysis was conducted accoding to PRISMA guideline.The articles concerning the diagnosis of residual or recurrent leision after TACE by using 18F-FDG PET/CT and/or CECT were systematically searched in databases including PubMed,Embase,Cochrane Library,Web of Science,CNKI,WanFang and VIP data.Two reviewers independently screened literature,extracted data,and assessed the risk of bias of included studies by using the QUADAS-2 tool.Then,this meta-analysis was performed by using Stata 12.0 software.The pooled weighted sensitivity and specificity were calculated,the summary receiver operating characteristic curve(SROC)was drawn and the area under the curve(AUC)was also calculated.Results Ten studies with 322 patients and 467 leisions on 18F-FDG PET/CT,thirteen studies with 748 patients and 943 leisions on CECT were finally included in our meta-analysis.Results of this research showed pooled Sen,Spe and AUC of 18F-FDG PET/CT in diagnosing residual or recurrent leision after TACE were 0.92(95%CI:0.87-0.94),0.95(95%CI:0.82-0.99),0.97(95%CI:0.93-0.99),respectively,and they were 0.72(95%CI:0.66-0.78),Spe=0.99(95%CI:0.93-1.00),AUC=0.87(95%CI:0.83-0.89)for CECT.In addition,the Sen and AUC value of CECT in diagnosing residual or recurrent leision after TACE were lower compared with 18F-FDG PET/CT(Sen:Z=2.34,P=0.02;AUC:Z=2.21,P=0.03).Conclusion In comparasion with CECT,18F-FDG PET/CT had excellent diagnostic value and may served as a noninvalsive imaging in diagnosing residual or recurrent leision after TACE.
Keywords:18F-FDG PET/CT  Contrast enhanced computed tomography  transcatheter arterial chemoembolization  Meta-a-nalysis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号